← Back to Search

Treatment arm for Post-Traumatic Stress Disorder (MR Trial)

N/A

Waitlist Available

Led By Jolie N. Haun, PhD MS BS

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Awards & highlights

MR Trial Summary

This trial will study whether the Mission Reconnect program can help manage chronic pain and PTSD symptoms for veterans and their families.

Eligible Conditions

Post-Traumatic Stress Disorder
Chronic Musculoskeletal Pain

MR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mission Reconnect effectiveness for PTSD symptoms

Mission Reconnect effectiveness for global health

Mission Reconnect effectiveness for physical symptoms

+1 more

Secondary outcome measures

Mission Reconnect effectiveness for social outcomes among Veterans

Mission Reconnect effectiveness for social outcomes among Veterans' partners

Other outcome measures

Veteran perceived value of Mission Reconnect in a sub-sample of Veteran participants

Veterans' partners perceived value of Mission Reconnect in a sub-sample of Veteran participants

MR Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Treatment armActive Control1 Intervention

Treatment Arm: MR is an user-driven, dyadic, self-care management program developed with NIMH funding (R43/44) for use by Veterans and their selected partners, individually or together, to reduce pain and distress and support physical, mental, and relationship health. MR was designed for Veterans who face obstacles accessing formal mental health services. It can also be used to complement formal services. MR is a patient-centered intervention, allowing users to determine the pace at which to proceed in each program component. MR Content. The program provides video and audio instruction in a set of 11 evidence-based wellness.

Group II: Control armPlacebo Group1 Intervention

Usual Care Waitlist Control Arm: For ethical reasons, this study will use a waitlist control arm to ultimately provide all participants exposure to the MR intervention. Dyads in the control arm will participate in all assessments like those in the treatment group, however, they will be asked to agree to not access the public web site during their participation. Wait-list control participants will be instructed to seek advice about treatment from their providers. Other than this initial advice, there will be no attempt by study personnel to influence condition management unless an issue (i.e., suicidal ideation) arises. The control condition will account for potential temporal effects that occur from passage of time (brief), and expectation effects associated with anticipation of MR participation. The control group will receive access to MR after they complete data collection.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,609 Previous Clinical Trials

3,306,131 Total Patients Enrolled

Jolie N. Haun, PhD MS BSPrincipal InvestigatorJames A. Haley Veterans' Hospital, Tampa, FL

1 Previous Clinical Trials

852 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this experiment still open to the public?

"According to clinicaltrials.gov, this trial has stopped recruitment at present; the initial post was published on September 3rd 2019 and last updated on April 14th 2022. However, there are 371 other studies actively seeking out patients right now."

Answered by AI